Suchergebnisse - "Acute lung injury"

PubPharm (308)

1

Post-pandemic acute respiratory distress syndrome : A New Global Definition with extension to lower-resource regions

enthalten in: Medicina intensiva | 2024

von Estenssoro, E. | González, I. | Plotnikow, G.

2

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia : A Randomized, Placebo-controlled, Double-blind, Multi-center, Phase III Trial to Assess the Efficacy and Safety of Trimodulin (BT588) in Adult Hospitalized Subjects With CAP Including COVID-19 Pneumonia.

enthalten in: ClinicalTrials.gov | 2024

3

Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients : Systematic Ultrasound Screening for Lower Extremity Deep Vein Thrombosis in ICU Patients With Severe COVID-19: a Randomized Clinical Trial.

enthalten in: ClinicalTrials.gov | 2024

4

Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury : Nebulized Heparin vs. Placebo for the Treatment of COVID-19 Induced Lung Injury

enthalten in: ClinicalTrials.gov | 2024

5

Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) : Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study

enthalten in: ClinicalTrials.gov | 2024

6

Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease) : Single Donor Banked Bone Marrow Mesenchymal Stromal Cells for the Treatment of COVID-19 Induced ARDS: A Non-Blinded Randomized, Controlled Study

enthalten in: ClinicalTrials.gov | 2024

7

Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors : Cardiac Magnetic Resonance for Tissue Characterization-Based Risk Stratification of Cardiopulmonary Symptoms, Effort Tolerance, and Prognosis Among COVID-19 Survivors

enthalten in: ClinicalTrials.gov | 2024

8

Prediction of acute lung injury assessed by chest computed tomography, oxygen saturation/fraction of inspired oxygen ratio, and serum lactate dehydrogenase in patients with COVID-19

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2024

von Matsubara, S. | Sudo, K. | Kushimoto, K. | +7

9

Personalized Targeted Immunomodulation in COVID-19 ARDS : Personalized Targeted Immunomodulation in Patients With ARDS Related to COVID19 and Future Pandemic Pathogens

enthalten in: ClinicalTrials.gov | 2024

10

A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS) : A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[31]